The presence of the PCSK9 mutation may have protected them from the development of a severe form of hypercholesterolemia, resulting in a mild to moderate hypercholesterolemia despite the presence of a pathologic mutation in LDLR. This evidence concerns the gene LDLR and familial hypercholesterolemia.